Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12

Alec Aeby1, Nathalie Poznanski, Denis Verheulpen

  • 1Department of Pediatric Neurology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. alec.aeby@ulb.ac.be

Epilepsia
|January 6, 2006
PubMed

Insights

Levetiracetam showed positive effects on EEG, behavior, and cognition in children with continuous spikes and waves during slow sleep (CSWS). Further research is needed to confirm its role in treating this epilepsy syndrome.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neurophysiology

Background:

  • Continuous spikes and waves during slow sleep (CSWS) is an epilepsy syndrome associated with significant behavioral and cognitive deterioration in children.
  • Identifying effective add-on treatments for CSWS is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the add-on efficacy of levetiracetam in children diagnosed with CSWS.
  • To assess levetiracetam's impact on electroencephalogram (EEG) patterns, behavior, and cognitive function.

Main Methods:

  • Retrospective chart review of children with CSWS treated with levetiracetam (50 mg/kg/day).
  • Analysis of EEG recordings and neuropsychological/behavioral assessments at baseline and 2 months post-treatment.
  • Long-term follow-up at 1 year for patients showing initial improvement.

Main Results:

  • Of 12 patients, 7 (58.3%) demonstrated EEG improvement; 3 of these showed neuropsychological gains, and 4 showed behavioral improvement.
  • Two patients improved neuropsychologically despite no EEG changes.
  • 8 patients (66.6%) continued levetiracetam beyond 2 months, with 4 remaining on it at 1 year due to sustained benefits.

Conclusions:

  • Levetiracetam appears to offer benefits for EEG, behavior, and cognition in pediatric patients with CSWS.
  • Further prospective studies are required to establish levetiracetam's definitive role in managing CSWS.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...